China pharmaceutical industry research & forecast to 2016 sample report

2,742 views

Published on

The present title on “China Pharmaceutical Industry Research and Forecast to 2016” offer detailed study on drugs market in terms of OTC, Patent and Generic drugs. Also assess industry performance in terms of recent developments, driving forces, regulatory structure, economy environment and political situation.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,742
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
83
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

China pharmaceutical industry research & forecast to 2016 sample report

  1. 1. 1© This is a licensed product of AM Mindpower Solutions and should not be copied
  2. 2. TABLE OF CONTENTS1. Global Pharmaceutical Market1.1. China Healthcare Sector1.1.1. Hospitals and Hospital Beds1.2. China Pharmaceutical Industry Snapshot2. China Pharmaceutical Industry2.1. Market Size2.2. China Pharmaceutical Market Forecast2.3. Chinese vaccine market2.4. Chemical and Bio-pharma Market2.5. Traditional Chinese Drugs Market2.5.1. Herbal Supplements MarketIssues in Approval for Chinese Herbal Medicines in the US3. Industry Classification3.1. Patent Drugs3.2. Generic Drugs4. Over the Counter Drugs (OTC)4.1. Market Size4.2. China Vitamin DemandVitamin EVitamin C5. Growth Drivers6. Industry Developments6.1. Recent Trends and opportunities6.2. Recent Pharmaceutical Industry M&A’s6.3. Regulatory Structure7. Country Analysis 2 © This is a licensed product of AM Mindpower Solutions and should not be copied
  3. 3. 7.1. Key Findings7.2. Political Environment7.3. Macro-economic Indicators7.3.1. GDP Recovery and Growth7.3.2. Import/Export7.3.3. Population and Literacy Rate7.3.4. Literacy Rate8. Industry Competition and Domestic Players Profiling8.1. Competitive Landscape8.2. Shanghai Pharmaceuticals (SPGC)8.3. Harbin Pharmaceuticals8.4. Pfizer China9. Appendix9.1. Abbreviations9.2. Definitions9.3. Research MethodologyData Collection MethodsApproach9.4. Disclaimer 3 © This is a licensed product of AM Mindpower Solutions and should not be copied
  4. 4. LIST OF FIGURESFigure 1: Global Pharmaceutical Market by Value (2006-2011E)Figure 2: China Healthcare Industry by Value (2006-2011)Figure 3: China Healthcare Industry Investment Trend (2006-2011)Figure 4: China Hospital Drugs Sales (2006-2011)Figure 5: Average Drug Cost per Inpatient and Outpatient (2006-2010)Figure 6: Chinese Pharmaceutical Industry Value ChainFigure 7: China Pharmaceutical Market Segments in 2011Figure 8: China Pharmaceutical Market by Value (2006-2011)Figure 9: China Drugs Retail Sales by Distribution Channels in % (2006-2011)Figure 10: China Pharmaceutical Retail Sales Forecast by Value (2011-2016)Figure 11: Traditional Chinese Medicine Market by Value (2006-2011)Figure 12: China Herbal Supplements Demand by value (2006-2015F)Figure 13: Patented Drugs Market Size by Value, (2006-2011)Figure 14: China Generic Drug Market Size by Value (2006-2011)Figure 15: OTC Drug Retail Sales by Value (2006-2011)Figure 16: China Vitamin Market by Value (2003-2015F)Figure 17: Aging Population Proportion in Chinese Total Population (2006-2011)Figure 18: China Per-Capita Disposable Income in Rural Areas (2006-2011E)Figure 19: Private Healthcare Expenditure in China (2006-20111f)Figure 20: Government Healthcare Expenditure in China (2006-2011F)Figure 21: China Urban per capita Disposable Income (2003-2010)Figure 22: China Gross Domestic Product (2003-2010)Figure 23: China Population (2003-2010)Figure 24: China Literacy Rate (2003-2010)Figure 25: Competition by Type of Players in 2011 4 © This is a licensed product of AM Mindpower Solutions and should not be copied
  5. 5. LIST OF TABLESTable 1: Leading Countries Market Share (2009-2011)Table 2: China Healthcare Institutions (2007-2010)Table 3: Chinese Vaccine Market by Value and Share in % (2006-2010)Table 4: Market Share of Major Chinese and Foreign Vaccines Companies by Class I andClass II Category in % by volume (2006-2009)Table 5: Market Share of Major Chinese and Foreign Vaccines Companies by Class I andClass II Category in % by Value (2006-2009)Table 6: China Chemical Drugs and Bio pharma Therapeutic Market in 2011Table 7: Bio-Pharma Products and Description in 2010Table 8: Average Medical Expenditure per Inpatient and Outpatient in Public Hospitals(2007-2010)Table 9: China Mergers and Acquisitions in 2010Table 10 : Country OverviewTable 11: China Economy (2010-2012)Table 12: Import & Export Statistics (Jan to May 2011)Table 13: Vitamin Import Data in China in January 2010Table 14: Chinese Herbal Medicines Imports and Exports (2008-2010)Table 15: Market Share of Leading Multinational Pharmaceutical Companies in China in2011Table 16: Shanghai Pharmaceuticals Revenue (2008-2010)Table 17: Shanghai Pharmaceuticals Key StrategiesTable 18: Harbin Pharmaceuticals Revenue Statement (2007-2010)Table 19: Harbin Pharmaceutical Key StrategiesTable 20: Pfizer China Key Strategies 5 © This is a licensed product of AM Mindpower Solutions and should not be copied
  6. 6. 1. GLOBAL PHARMACEUTICAL MARKETTrends towards healthy lifestyles and rising healthcare awareness have become a globalphenomenon. The pharmaceutical industry is one of the leading industries worldwide as a result of increased efforts to reduce mortality and China pharmaceutical industry morbidity, the technological advancements in medical was ranked on 5th place in 2011 and is soon expected to outpace facilities & treatment, and the aging segment of the Germany and Japan society. In the first quarter of 2010, advertising expenditures on pharmaceutical products grew 3.60%as compared to the same period last year, generating USD 1.79 billion revenues. In 2011, theUS continued to dominate the worldwide pharmaceutical market with around ~% marketshare along with strong growth registered by Latin American and Asian pharmaceuticalmarkets. The pharmaceutical market in Europe declined for third consecutive year in 2011mainly because of Euro’s weaker exchange rate against the USD. The Chinesepharmaceutical industry is soon expected to outpace Germany and Japan.Figure: Global Pharmaceutical Market by Value (2006-2011E) 1,000 900 800 700 USD Billion 600 500 400 300 200 100 0 2006 2007 2008 2009 2010 2011ETable: Leading Countries Market Share (2009-2011)Countries 2009 2010 2011The USJapanGermanyChina 6 © This is a licensed product of AM Mindpower Solutions and should not be copied
  7. 7. CHINA HEALTHCARE SECTORChinese healthcare industry encompasses pharmaceuticals, healthcare institutions (hospitals,nursing homes, clinics, and diagnostic centers), medical devices and health insurancecompanies. Both public and private sectors are contributing in the industry growth with private sector providing huge investments in building Government’s viable regulations the infrastructure while public sector offering low for foreign investment in Chinese pharmaceutical industry are cost healthcare services. The total healthcare industry supporting the industry growth in the country has reached USD ~ billion in 2011 at a growth rate of 16.67% from previous year and isexpected to grow by 22.00% by 2016 led by medical equipment demand and rising demandof pharmaceutical industry.Figure: China Healthcare Industry by Value (2006-2011) 350.00 300.00 250.00USD Billion 200.00 150.00 100.00 50.00 0.00 2006 2007 2008 2009 2010 2011Figure: China Healthcare Industry Investment Trend (2006-2011) 4,500.00 4,000.00 3,500.00 3,000.00USD Million 2,500.00 2,000.00 1,500.00 1,000.00 500.00 0.00 2006 2007 2008 2009 2010 2011 7 © This is a licensed product of AM Mindpower Solutions and should not be copied
  8. 8. In 2010 & 2011 hospital drugs sales grew by 21.25% In 2010 & 2011, hospital drugs and 20.27% respectively. The fall in the revenue growth sales grew by 21.25% and rate was largely due to the government’s price control 20.27% policy. The necessity of the treatment is helping drugmanufacturers to cover their losses from the new pricing reform. In coming years, price indexwill fall further but in terms of volume, sales are expected to register positive growth.Figure: China Hospital Drugs Sales (2006-2011) 40.00 35.00 30.00 25.00 USD Billion 20.00 15.00 10.00 5.00 0.00 2006 2007 2008 2009 2010 2011Figure: Average Drug Cost per Inpatient and Outpatient (2006-2010) 100.00 90.00 80.00 70.00 60.00 RMB 50.00 Inpatient Outpatient 40.00 30.00 20.00 10.00 0.00 2006 2007 2008 2009 2010 8 © This is a licensed product of AM Mindpower Solutions and should not be copied
  9. 9. HOSPITALS AND HOSPITAL BEDSWith rising number diseases, number of healthcare facilities has also showed signs ofimprovement to balance demand and supply but the limiting factor is the number of trainedmedical practitioners which have become an area of concern. Now government’s next agendais to encourage students to opt for medical services.Table: China Healthcare Institutions (2007-2010) 2007 2008 2009 2010HospitalGrass-roots Healthcare InstitutionSpecialized Public Health InstitutionOther InstitutionTotalCHINA PHARMACEUTICAL INDUSTRYMARKET SIZEChinese pharmaceutical industry is showing a consistent growth and now moving forward tooutpace other leading markets. Rising per capita disposable income, government measures to support healthcare (introduction of cost effective Prescription drugs dominate the policies) and a large number of rural population pharmaceutical market in the country in terms of both moving to urban areas are the major factors driving the production and retail sales industry growth. The Chinese pharmaceutical market is dominated by prescription drugs in terms of bothproduction and retail sales which contributed 38% to the total pharmaceutical retail sales in2011. Cold and flu medicines accounted for the largest demand in the OTC segment whilediabetes, hypertension and heart diseases drugs were driving the demand in the prescriptiondrugs segment. 9 © This is a licensed product of AM Mindpower Solutions and should not be copied
  10. 10. Figure: China Pharmaceutical Market Segments in Percentage, 2011 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% OTC Drugs Prescription Drugs TCM OthersNote: Others includes a portion of medical devices and illegal drugs which are either banned or imported from othercountriesFigure: China Pharmaceutical Market by Value (2006-2011) 70.00 60.00 50.00 USD Billion 40.00 30.00 20.00 10.00 0.00 2006 2007 2008 2009 2010 2011Introduction of EDI (essential drug list) has left an inverse impact over small drugdistributors; MoH is signing contracts with distributors who can spread their reach nationallyto standardize the drug distribution system. 10 © This is a licensed product of AM Mindpower Solutions and should not be copied
  11. 11. Figure: China Drugs Retail Sales by Distribution Channels in % (2006-2011) 100.0% 90.0% 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% 2006 2007 2008 2009 2010 2011 Medical Institutions/Hospitals & Clinics Retail Drug StoresCHINA PHARMACEUTICAL MARKET FORECASTModern Chinese medicine demand is rising and it is expected that in coming years MCM willgrow at 17% growth rate led by the rise in exports. A large demand for Chinese herbalsupplements is also expected from European countries with the help of improved technologyand rising interest of international pharmaceutical companies. Chemical drugs are expected togrow at 16% growth rate by 2014. OTC drugs demand in chain drug stores is rising comparedto pharmacies because of the display and higher self life. From 2011-2016, the Chinesepharmaceutical industry is expected to grow at CAGR 14.36% generating revenues of USD ~billion.Figure: China Pharmaceutical Retail Sales Forecast by Value (2011-2016) 160.00 140.00 120.00 USD Billion 100.00 80.00 60.00 40.00 20.00 0.00 2011 2012F 2013F 2014F 2015F 2016F 11 © This is a licensed product of AM Mindpower Solutions and should not be copied
  12. 12. CHINESE VACCINE MARKETVaccine market is witnessing a rapid growth in the country wherein a major portion of salesin volume terms comes from Class I vaccine 1 but in terms of value its contribution is low.With the help of state immunization program, demand for Class I vaccine increased by 94.9%in 2010 to USD 920 million.Table: Chinese Vaccine Market by Value and Share in % (2006-2010) Share (%) Sales Value Share (%) by Year Class by Value Volume (USD Million) Class I Class II2006 Total Class I Class II2007 Total Class I Class II2008 Total Class I Class II2009 Total Class I Class II2010 TotalCHEMICAL AND BIO-PHARMA MARKETChemical drugs hold the largest share in the Chinese pharmaceutical market and showed arelatively strong growth in 2011. Among Chemical and Bio-pharma therapeutic productsanti-infective, Antineoplastic and Cardiovascular accounted for the largest demand.1 Class I vaccines (vaccines purchased by the government for the state immunization programs) and class II vaccines (self-paid vaccines) 12 © This is a licensed product of AM Mindpower Solutions and should not be copied
  13. 13. Table: China Chemical Drugs and Bio pharma Therapeutic Market in 2011Therapeutics Market Size USD millionAnti-Invectives for Systemic UseAntineoplastic and Immuno-Modulating AgentsCardiovascular SystemNervous SystemRespiratory SystemBio-pharma products are slowly gaining importance in the pharmaceutical industry withsector growth driven by recent acquisitions. Retail sales in this segment recorded 27.00% and28.40% growth in 2010 and 2011 respectively.Table: Bio-Pharma Products and Description in 2010 National List Patent Prescription NMID of Essential Product Name Usage Expiry Drug OTC Drugs DrugsUlinastatin forInjectionPeifelkang (LiveCombinedBifidobacterium,Lactobacillus andEnterococcusCapsules, Oral))UrinaryKallidinogenase forinjectionChymotrypsin forInjectionNote: NMID stands for National Medical Insurance Drugs 13 © This is a licensed product of AM Mindpower Solutions and should not be copied
  14. 14. TRADITIONAL CHINESE DRUGS MARKETA large proportion of rural population in China prefers traditional medicines with most of thegeneral hospitals operating a separate TCM department. Outside China, TCM is becoming popular with rising exports in both value and volume terms. In In 2011, Traditional recent years, Modern Chinese medicines (MCM) have replaced Chinese Market drug sales traditional medicines with continuous research and registered 2.11% growth to USD ~ billion developments and advancements in proteomics, genomics, molecular biology and stem cell research. This segment of theIn 2011, TCM sales grew by 2.11% to USD ~ billion as compared to 3.74% growthregistered in 2010 with market worth of USD ~ billion..Figure: Traditional Chinese Medicine Market by Value (2006-2011) 30.00 25.00USD Billion 20.00 15.00 10.00 5.00 0.00 2006 2007 2008 2009 2010 2011EHERBAL SUPPLEMENTS MARKETChina is specialized in the field of herbal medicine, thus finding a greater demand for theirtraditional herbal products. From 2005-2010, the Chinese herbal medicine market grew at aCAGR of 4.38%, to USD ~ billion in 2010. The market is expected to grow by 7.69% CAGRfrom 2010 to 2015F. 14 © This is a licensed product of AM Mindpower Solutions and should not be copied
  15. 15. Figure: China Herbal Supplements Demand by Value (2006-2015F) 7.00 6.00 USD Billion 5.00 4.00 3.00 2.00 1.00 0.00 2006 2007 2008 2009 2010 2011E 2012F 2013F 2014F 2015FPATENT DRUGSIn China, patented drugs market is small but registered a continuous growth even during economy slowdown. A stable growth is the result of Patented drugs sales grew at literate segment of the population and migrates who CAGR 28.19% from 2006 to USD believe in paying high on drugs for better cure. Per ~ million in 2011 capita income is also rising which support spendingpower wherein healthcare is on top priority.Figure: Patented Drugs Market Size by Value, (2006-2011) 6,000.00 5,000.00 4,000.00 USD Million 3,000.00 2,000.00 1,000.00 0.00 2006 2007 2008 2009 2010 2011 15 © This is a licensed product of AM Mindpower Solutions and should not be copied
  16. 16. GENERIC DRUGSGeneric drugs market is witnessing a rapid growth wherein small domestic players hold adominant position. With the expiry of patent of branded drugs, domestic companies try to first launch the drug. There are almost ~ Generic segment enjoy dominant pharmaceutical companies working in the country position in the market driven by including domestic as well as foreign players. By the rising interest of foreign investors as well as number of end of 2011, generic drugs market reached USD ~ M&A activities billion by growing at a CAGR ~% from 2006-2011.Figure: China Generic Drug Market Size by Value (2006-2011) 60.00 50.00 40.00 USD Billion 30.00 20.00 10.00 0.00 2006 2007 2008 2009 2010 2011OVER THE COUNTER DRUGS (OTC)In value terms, OTC drug market reached USD ~ billion 2 and demand was high in retailstores compared to the hospitals. In terms of disease type, cold & flu medicines accounted forthe largest sales by volume. Also vitamins, minerals and gastrointestinal medicationsupported OTC demand. The historical figures suggested a stable growth in OTC market andaccording to the present sales, growth rate is improving year on year. In Chain, drug storesare rapidly expanding due to the availability of all types of drugs (herbal, chemical) at oneplace.2 This figure include herbal medicines including traditional Chinese medicines 16 © This is a licensed product of AM Mindpower Solutions and should not be copied
  17. 17. Figure: OTC Drug Retail Sales by Value (2006-2011) 18.00 16.00 14.00 12.00 USD Billion 10.00 8.00 6.00 4.00 2.00 0.00 2006 2007 2008 2009 2010 2011Source: AM Mindpower SolutionsCHINA VITAMIN DEMANDIn the past decade, demand for vitamins in China have grown at a fast pace. In terms ofproduction volume, country has experienced rise in demand in 2010 as compared to previous years, with large demand coming for vitamin C In term of value, vitamin supplements. In term of value, vitamin market grew by market grew by 9.48% in 2010 to USD ~ million 9.48% in 2010 to USD ~ million as compared to 2009 results. China vitamin demand is expected to surpassUSD ~ million by 2015, driven by rising population and economic growth of the country.Further, a large educated and urban population accompanied with rising personal disposableincome will support the demand for vitamins to increase immunity and fight chronic diseases.Figure 1: China Vitamin Market by Value (2003-2015F) 1,400 1,200 1,000USD Million 800 600 400 200 0 2003 2004 2005 2006 2007 2008 2009 2010 2011E 2012F 2013F 2014F 2015F 17 © This is a licensed product of AM Mindpower Solutions and should not be copied
  18. 18. DISCLAIMERNo part of this manual or any material appearing may be reproduced, stored in ortransmitted on any other Web site without written permission of AM Mindpower Solutionsand any payments of a specified fee. Requests to republish any material may be sent to us.For more information please refer to the below mentioned link:http://www.ammindpower.com/report.php?A=255 18 © This is a licensed product of AM Mindpower Solutions and should not be copied

×